NINLARO Capsules 0.5mg

NINLARO (ixazomib citrate) capsules, 0.5mg (YJ code: 4291049M4023, standard: 0.5mg 1 capsule), manufactured by Takeda Pharmaceutical, are a proteasome inhibitor used in combination with lenalidomide and dexamethasone to treat adult patients with multiple myeloma who have received at least one prior therapy. It works by blocking protein breakdown in cancer cells, causing a buildup of proteins that leads to cell death.